VGX Pharmaceuticals LLC has a total of 25 patent applications. Its first patent ever was published in 2003. It filed its patents most often in Canada, EPO (European Patent Office) and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are VGX PHARMACEUTICALS INC, EPICENTRX INC and ENGENEIC MOLECULAR DELIVERY PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 5 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | Republic of Korea | 5 | |
#4 | Australia | 2 | |
#5 | United States | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | China | 1 | |
#8 | Japan | 1 | |
#9 | Mexico | 1 | |
#10 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Climate change adaptation technologies | |
#6 | Electrotherapy | |
#7 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Draghia-Akli Ruxandra | 10 |
#2 | Sardesai Niranjan Y | 7 |
#3 | Khan Amir S | 5 |
#4 | Kjeken Rune | 4 |
#5 | Ramanathan Mathura P | 4 |
#6 | Mccoy Jay | 4 |
#7 | Draghia Akli Ruxandra | 4 |
#8 | Fons Michael P | 4 |
#9 | Kemmerrer Stephen Vincent | 4 |
#10 | Kardos Thomas Joseph | 4 |
Publication | Filing date | Title |
---|---|---|
EP2419169A1 | Contactless electropermeabilization electrode and method | |
CN105400798A | Antigens that elicit immune response against flavivirus and methods of using same | |
CA2708668A1 | Vaccines against multiple subtypes of dengue virus | |
CA2702971A1 | Antibody production elicited by a dna vaccine delivered by electroporation | |
US2010247437A1 | Materials and methods for the delivery of biomolecules to cells of an organ | |
NZ553274A | Growth hormone releasing hormone enhances the immune response induced by vaccination | |
EP1713828A2 | Enhanced secretion/retention of growth hormone releasing hormone (ghrh) from muscle cells by species-specific signal peptide | |
EP1711187A2 | Reducing arthritis and lameness in subjects by growth hormone releasing hormone (ghrh) supplementation |